Frederick Financial Consultants’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$753K Sell
26,300
-99
-0.4% -$2.88K 0.37% 47
2025
Q4
$747K Sell
26,399
-6,328
-19% -$179K 0.41% 45
2025
Q3
$915K Sell
32,727
-1,868
-5% -$50.8K 0.51% 40
2025
Q2
$909K Sell
34,595
-2,561
-7% -$63.5K 0.56% 39
2025
Q1
$938K Sell
37,156
-1,845
-5% -$46.9K 0.68% 31
2024
Q4
$965K Buy
+39,001
New +$1.01M 0.77% 29

Other funds holding REVS

Frederick Financial Consultants's REVS Position: Q1 2026 in Review

Frederick Financial Consultants reduced its Columbia Research Enhanced Value ETF (REVS) stake by 0.38% in Q1 2026, selling an estimated $2.88K and leaving 26,300 shares worth $753K. The position accounts for 0.37% of the portfolio, ranked #47.

Frederick Financial Consultants first reported a position in REVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $965K in Q4 2024. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • Frederick Financial Consultants held 26,300 shares of Columbia Research Enhanced Value ETF worth $753K as of Q1 2026.
  • Frederick Financial Consultants sold 99 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $2.88K.
  • Columbia Research Enhanced Value ETF made up 0.37% of Frederick Financial Consultants's portfolio in Q1 2026, its #47 holding.
  • Frederick Financial Consultants first reported a position in Columbia Research Enhanced Value ETF in Q4 2024 and has held it in 6 quarters since.
  • Frederick Financial Consultants's Columbia Research Enhanced Value ETF position peaked at $965K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on Frederick Financial Consultants's 13F filing for Q1 2026, filed 14 May 2026.